Skip to content

Skip to secondary menu

Jehovah’s Witnesses


Hematology (Oncology)

Management of Thrombocytopenia

Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.

Berthelot-Richer M, Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.

Source‎: Transfusion 2012;52(4):739-41.

Indexed‎: PubMed 22082044

DOI‎: 10.1111/j.1537-2995.2011.03382.x

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia.

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Source‎: Can J Cardiol 2011;27(6):869.e7-8.

Indexed‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness.

Walia SS, Walia MS, Walia HS.

Source‎: Asian J Transfus Sci 2011;5(2):180-1.

Indexed‎: PubMed 21897605

DOI‎: 10.4103/0973-6247.83255

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.

Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S.

Source‎: J Neurooncol 2012;106(2):427-9.

Indexed‎: PubMed 21833801

DOI‎: 10.1007/s11060-011-0675-5

Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma.

Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG.

Source‎: Pathol Oncol Res 2011;17(1):141-3.

Indexed‎: PubMed 20628840

DOI‎: 10.1007/s12253-010-9276-4

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Source‎: Blood 2010;116(12):2127-33.

Indexed‎: PubMed 20530792

DOI‎: 10.1182/blood-2010-03-276691

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.